Latest News - Moderna
Top Corporates Hub
Moderna
Analysts Name 9 'Left Out' Stocks With Huge Upside Ahead
29.10.2025 12:00
When the S&P 500 is rallying to all-time highs, you have to wonder about the stocks getting left out. Turns out analysts see great promise.
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
20.10.2025 04:32
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
Moderna (MRNA) Stock Trades Up, Here Is Why
13.10.2025 16:21
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped in the afternoon session after the company presented promising early data for its investigational cancer antigen therapy, mRNA-4359, from a Phase I/II study.
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
13.10.2025 12:30
Moderna (MRNA) said Monday that its investigational cancer antigen therapy, mRNA-4359, in combinatio
3 Cash-Burning Stocks with Warning Signs
13.10.2025 04:46
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even bankruptcy.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
10.10.2025 13:00
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
AstraZeneca ups investment in Virginia; Moderna vets launch VC fund
10.10.2025 09:07
The British pharma is adding $500 million, and ADC production capabilities, to a planned Virginia facility. Elsewhere, Ferring announced layoffs and Sanofi touted a radiopharmaceutical drug.
Venture financing for mRNA-based vaccines declines 82% in 2025 YTD
07.10.2025 10:14
Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.
2 Beaten-Down Stocks to Buy and Hold for a Decade
30.09.2025 11:30
These biotechs should benefit from their innovative ways.
Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript
25.09.2025 12:37
Moderna, Inc. (NASDAQ:MRNA) Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum September 25, 2025 10:30 AM EDTCompany...
Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum - Slideshow
25.09.2025 11:00
2025-09-25. The following slide deck was published by Moderna, Inc.
Moderna opens UK vaccine manufacturing facility
25.09.2025 10:55
MITC will manufacture vaccines for respiratory illnesses, supporting the National Health Service's vaccination programmes.
Moderna opens new manufacturing and R&D facility in the UK
25.09.2025 09:34
The MITC in Harwell, Oxfordshire, is now fully operational.
Moderna opens mRNA production center in UK
25.09.2025 07:35
Moderna announces the opening of the Moderna Innovation and Technology Centre in Harwell, Oxfordshire, the first facility in the UK to produce mRNA vaccines locally. The site will support the NHS ...
Flagship Pioneering, Creator Of Moderna, Launches Extuitive With $20M To Reinvent Consumer Products Using AI Shoppers
24.09.2025 01:01
Flagship Pioneering, the Cambridge venture firm known for creating Moderna (NASDAQ:MRNA), last Thursday unveiled a new startup called Extuitive with $20 million in seed funding. The company said the platform is designed to equip small businesses with artificial intelligence tools that simulate consumer behavior, a capability historically used by large corporations. The startup launch represents a change for the 26-year-old firm that built its reputation by fostering life sciences companies worth
Stocks making big moves yesterday: Plug Power, Moderna, Magnite, Compass, and RE/MAX
23.09.2025 13:00
Check out the companies making headlines yesterday:
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
23.09.2025 11:00
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune ...
Trump's battle with the pharma industry shows no signs of easing
18.09.2025 10:00
Drug makers are battling vaccine restrictions, pricing pressures, tariff threats, and Health Secretary Robert F. Kennedy, Jr.
Why Moderna (MRNA) Stock Is Trading Up Today
16.09.2025 16:40
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®.